ACT — AlzChem AG Balance Sheet
0.000.00%
- €1.04bn
- €1.03bn
- €554.23m
- 93
- 28
- 60
- 67
Annual balance sheet for AlzChem AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17.1 | 8.29 | 14.5 | 11.9 | 61.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 40.5 | 50.3 | 70.5 | 89.3 | 91 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 132 | 153 | 215 | 217 | 262 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 184 | 186 | 188 | 182 | 197 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 354 | 378 | 423 | 425 | 484 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 59.9 | 76.1 | 132 | 82.6 | 105 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 287 | 290 | 279 | 263 | 278 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 66.9 | 87.6 | 144 | 162 | 206 |
Total Liabilities & Shareholders' Equity | 354 | 378 | 423 | 425 | 484 |
Total Common Shares Outstanding |